Search Results for 'treatment 2015'

treatment 2015 published presentations and documents on DocSlides.

addendum to the 2015 Treatment Subcommittee MCL Support Document

addendum to the 2015 Treatment Subcommittee MCL Support Document

by hanah

“recommendation on . perfluorinated. compound t...

Fast-Tracking Treatment to End AIDS

Fast-Tracking Treatment to End AIDS

by tatyana-admore

ICASA. Ambassador . Deborah Birx, MD. U.S. . Glob...

ObG Watch Narayanan R September 2015

ObG Watch Narayanan R September 2015

by walsh

Elisabeth Bing, ‘. Mother of Lamaze’ Dies . at...

Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir

Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir

by pamella-moone

SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...

Applying Science to Improve the Individualized Treatment of Patients with Psoriasis

Applying Science to Improve the Individualized Treatment of Patients with Psoriasis

by thesoysi

Abrar Qureshi, MD, MPH. Chief of the Department of...

Addiction 101: History, Etiology, & Treatment

Addiction 101: History, Etiology, & Treatment

by morgan

Thomas M. Workman, PhD, LPC, NCC, ACS. Kevin Carid...

Law and order; crime and punishment.

Law and order; crime and punishment.

by conchita-marotz

How can the scales of justice be balanced morally...

REVISED 2015-09-11

REVISED 2015-09-11

by alexa-scheidler

Around 60,000 people in Sweden will get cancer th...

Sarah Wakeman MD

Sarah Wakeman MD

by tatiana-dople

, FASAM. (No Disclosures). Joshua D Lee MD MSc, F...

Ethical and Clinical Considerations for Mental Health Profe

Ethical and Clinical Considerations for Mental Health Profe

by aaron

Dr. Ronn Johnson, Ph.D.,AB...

by danika-pritchard

Street Forums . Engineering Services. Department ...

by alexa-scheidler

the 2015 Treatment Subcommittee MCL Support Docu...

Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]

Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]

by danika-pritchard

Strategies To Identify and Advance PWID HCV Patie...

Technical Assistance Webinar:

Technical Assistance Webinar:

by lois-ondreau

FOA TI-16-006 . Cooperative Agreements for Adoles...

May 7 th 2013 Carol Odula-Obonyo

May 7 th 2013 Carol Odula-Obonyo

by min-jolicoeur

Senior Medical O. fficer . - . Obs. /. Gyn. (UHS...

ContentslistsavailableatJournalofAectiveDisordersjournalhomepagewwwels

ContentslistsavailableatJournalofAectiveDisordersjournalhomepagewwwels

by erica

ResearchpaperVeteransGroupExerciseArandomizedpilot...

by giovanna-bartolotta

PHY 752 Spring 2015 -- Lecture 28. 1. PHY 752 So...

CROI 2015: What’s New in Hepatitis?

CROI 2015: What’s New in Hepatitis?

by myesha-ticknor

Nina Kim, MD . Associate Professor of Medicine. D...

New Directions in the future 2015

New Directions in the future 2015

by mitsue-stanley

Consolidated ARV Guidelines Update. Meg . Doherty...

Cancer Prostate November, 2015

Cancer Prostate November, 2015

by BraveButterfly

1. Global Burden of Disease Cancer Collaboration, ...

CROI 2015: Treatment and Cure Highlights

CROI 2015: Treatment and Cure Highlights

by unita

Shireesha Dhanireddy. Robert Harrington. March 17,...

by tatyana-admore

. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...

by min-jolicoeur

Paritaprevir. -. Ritonavir (. Technivie. ). Prepa...

State Policy Issues: 2015

State Policy Issues: 2015

by luanne-stotts

Alison Haddock, MD, FACEP. Assistant Professor, B...

Mental Health and Substance

Mental Health and Substance

by test

abUse. National Healthcare Quality . and . Dispar...

World Tuberculosis Day 2015

World Tuberculosis Day 2015

by luanne-stotts

The TB situation in 2013. :. Findings from the j...

Update on Follicular Lymphoma:

Update on Follicular Lymphoma:

by alexa-scheidler

Contemporary Treatment Strategies and Optimal Seq...

Weaving together addictions and developmental disabilities:

Weaving together addictions and developmental disabilities:

by giovanna-bartolotta

diagnosis. Elspeth Slayter, PhD. National Associa...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by jane-oiler

(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...

Bridging our mandates: Evidence Based Practice and Patient

Bridging our mandates: Evidence Based Practice and Patient

by tawny-fly

Nan Bernstein Ratner. University of Maryland. nra...

by giovanna-bartolotta

Cancer Research Progress. Major Advances in Medic...

Speech Therapy’s Role in Head and Neck Cancer

Speech Therapy’s Role in Head and Neck Cancer

by tatiana-dople

Presented By: Jodi Peabody, MS CCC-SLP. Date: 09/...

by pamella-moone

+ . Grazoprevir. in . GT 1 . and Chronic Renal ...

3 Lessons Learned from a PAM Survivor

3 Lessons Learned from a PAM Survivor

by calandra-battersby

W. Matthew Linam, MD, MS. Objectives. Discuss fac...

Transdisciplinary foundation II:

Transdisciplinary foundation II:

by yoshiko-marsland

Treatment knowledge. Contributor: Lori Phelps. Lo...

Hemophagocytic Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis

by olivia-moreira

By: Michelina Kauffman, MD PGY-3. December 4, 201...

OPIOID EPIDEMIC

OPIOID EPIDEMIC

by ellena-manuel

. Opiates and opioid drugs. ...

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

by debby-jeon

. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...

Practice Update: Buprenorphine

Practice Update: Buprenorphine

by lois-ondreau

Claire F. Johnson, RN-BSN, PMHNP-DNP Student. Dis...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by trish-goza

in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...